A conceptual model of food cue reactivity, Nutrients (2023) Taking a GLP-1
10.3389/fcimb.2023.1001973 60 KapilS.SinghP
Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous semaglutide 7.2 mg for obesity Novo Nordisk announced headline results from STEP UP, a phase IIIb trial in the global STEP programme

Patient with risk factors for venous insufficiency, and/or showing symptoms of varicose veins, should avoid: Sodium Consuming more than 2300 mg of sodium per day causes fluid retention, which adds pressure to the veins and increases the likelihood of developing varicose veins Sugar Consuming more than 36g of sugar (for men) and 25g of sugar (for women) contributes to weight gain and diabetes, a known factor for vein disease Fried foods heavy in saturated fats, which clogs the arteries and restrict blood flow Dairy slows down the digestive system, can cause constipation which enables vein swelling Processed meats high in sodium, causes water retention which restricts circulation Alcohol dehydrates the venous system, slowing circulation CAN I TREAT MY VARICOSE VEINS THROUGH DIET
Both formulations work through the same GLP-1 receptor mechanism
Furthermore, we discuss whether effects are specific for semaglutide or a class effect